449 results on '"Schopohl, J"'
Search Results
102. Pain characteristics in acromegalic patients compared to patients with non-functioning pituitary adenomas
103. Leptin serum levels during an oral glucose tolerance test in growth hormone deficiency and acromegaly
104. OR1,5 Chronic growth hormone (GH) excess is associated with increased aldosterone in mice and humans
105. Serum Leptin and Ghrelin Levels in Active and Inactive Acromegalic Patients During an Oral Glucose Tolerance Test
106. Endogenous estradiol may influence IGF-I levels in acromegalic women treated with pegvisomant
107. Morphologie und Klinik des Thymuskarzinoids
108. Diagnostische Kriterien für die Indikation zur Wachstumshormon-Substitution bei Erwachsenen
109. Autorenverzeichnis
110. A shifted psychopathological risk profile in acromegalic patients?
111. Acute effect of the growth hormone antagonist pegvisomant injection alone and in combination with a somatostatin analogue on endogenous GH and pegvisomant levels
112. Acromegalic patients: more depressed, without panic? The 'endocrine psychosyndrome' of acromegaly revised
113. Ghrelin and leptin serum levels during an oral glucose tolerance test in active and inactive acromegalic patients
114. Nocturnal asthma. Beta 2-adrenoceptors on peripheral mononuclear leukocytes, cAMP- and cortisol-plasma concentrations
115. Case report: Estradiol lowers IGF-I in a 46 year old acromegalic female treated with pegvisomant
116. Effects of the long-acting somatostatin analogue Lanreotide Autogel on glucose tolerance and insulin resistance in acromegaly
117. A patient with hypercalcaemic crisis due to parathyromatosis successfully treated with cinacalcet
118. Ectopic Cushing's syndrome due to an ACTH and CRH producing mediastinal paraganglioma
119. Evaluation of glucose-suppressed GH and IGF-I levels in patients with active and inactive acromegaly
120. Sonographische Evaluation abdomineller Organe bei Patienten mit Akromegalie
121. A 59 year old patient with metastases of gastrinoma in the context of MEN-1 treated with Sandostatin – surgical revision versus conservative therapy
122. Elevated incidence of sleep apnea in acromegaly – correlation to disease activity
123. Gamma-Knife Surgery is Effective in Normalising Plasma Insulin-Like Growth Factor I in Patients with Acromegaly
124. Four-Year Follow-Up of Acromegalic Patients Treated with the New Long-Acting Formulation of Lanreotide (Lanreotide Autogel)
125. Effects of long acting somatostatin analogues on glucose tolerance and insulin resistance in acromegaly
126. Endogenous GH levels after growth hormone receptor antagonist treatment with and without additional Octreotide
127. Patients with Septic Shock Show Impaired Adrenal Hormone Synthesis
128. Four year results of Lanreotide Autogel treatment in acromegalic patients
129. Selenium substitution has no direct effect on thyroid hormone metabolism in critically ill patients
130. Long-standing active acromegaly increases cardiac risk by reducing heart rate variability
131. Evidence for impaired 21-hydroxylase activity in patients with septic shock
132. Gamma-knife irradiation is effective in normalising plasma insulin-like growth factor I in patients with acromegaly
133. Acromegaly due to GHRH-secreting large bronchial carcinoid. Complete recovery following tumor surgery
134. Conventional pituitary irradiation is effective in normalising plasma IGF-I in patients with acromegaly
135. Hormones and not gender influences outcome in severe infection
136. The influence of hyperthyroidism on the hypothalamic-pituitary-gonadal axis
137. Steroid hormone synthesis is impaired in patients with severe sepsis
138. Ultrasonic integrated backscatter identifies promptly effects of coronary artery reperfusion after acute myocardial infarction
139. Selenium substitution in patients with severe systemic inflammatory response syndrome (SIRS)
140. The decrease in growth hormone (GH) response after repeated stimulation with GH-releasing hormone is partly caused by an elevation of somatostatin tonus.
141. Effect of growth hormone (hGH) replacement therapy on physical work capacity and cardiac and pulmonary function in patients with hGH deficiency acquired in adulthood.
142. Growth hormone (GH)-releasing peptide stimulation of GH release from human somatotroph adenoma cells: interaction with GH-releasing hormone, thyrotropin-releasing hormone, and octreotide.
143. Kallman syndrome versus idiopathic hypogonadotropic hypogonadism at MR imaging.
144. Olfactory function in patients with hypogonadotropic hypogonadism: an all-or-none phenomenon?
145. In Man the Mu-Opiate Agonist Loperamide Specifically Inhibits ACTH Secretion Induced by the Cholecystokinin-Like Peptide Ceruletide
146. Increased Prevalence of Anxiety-Associated Personality Traits in Patients with Cushing's Disease: A Cross-Sectional Study.
147. Pulsatile gonadotrophin releasing hormone versus gonadotrophin treatment of hypothalamic hypogonadism in males
148. Efficacy and Acceptability of Lanreotide Autogel 120 mg at Different Dose Intervals in Patients with Acromegaly Previously Treated with Octreotide LAR.
149. Ultrasonic integrated backscatter delineates beneficial effects of coronary artery revascularization therapy after acute myocardial infarction.
150. Outcome in elderly patients with severe infection is influenced by sex hormones but not gender.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.